References
- Agirre X, Roman-Gomez J, Vazquez I, Jimenez-Velasco A, Garate L, Montiel-Duarte C, Artieda P, Cordeu L, Lahortiga I, Calasanz MJ, Heiniger A, Torres A, Minna JD, Prosper F. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer. 2006. 118: 1945-1953. https://doi.org/10.1002/ijc.21584
- Altieri DC. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem. 2004. 92: 656-663. https://doi.org/10.1002/jcb.20140
- Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009. 9: 361-371. https://doi.org/10.1038/nrc2628
- Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004. 432: 324-331. https://doi.org/10.1038/nature03100
-
Capaldo CT, Beeman N, Hilgarth RS, Nava P, Louis NA, Naschberger E, Sturzl M, Parkos CA, Nusrat A. IFN-
${\gamma}$ and TNF-${\alpha}$ -induced GBP-1 inhibits epithelial cell proliferation through suppression of${\beta}$ -catenin/TCF signaling. Mucosal Immunol. 2012. 5: 681-690. https://doi.org/10.1038/mi.2012.41 -
Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang CY. Wnt-1 signaling inhibits apoptosis by activating
${\beta}$ -catenin/T cell factor-mediated transcription. J Cell Biol. 2001. 152: 87-96. https://doi.org/10.1083/jcb.152.1.87 - Denison SR, Callahan G, Becker NA, Phillips LA,Smith DI. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer. 2003a. 38: 40-52. https://doi.org/10.1002/gcc.10236
- Denison SR, Wang F, Becker NA, Schule B, Kock N, Phillips LA, Klein C, Smith DI. Alterations in thecommon fragile site gene Parkin in ovarian and other cancers. Oncogene. 2003b. 22: 8370-8378. https://doi.org/10.1038/sj.onc.1207072
-
Franco DL, Nojek IM, Molinero L, Coso OA, Costas MA. Osmotic stress sensitizes naturally resistant cells to TNF-
${\alpha}$ -induced apoptosis. Cell Death Differ. 2002. 9: 1090-1098. https://doi.org/10.1038/sj.cdd.4401074 - Heeg-Truesdell E, LaBonne C. Wnt signaling: a shaggy dogma tale. Curr Biol. 2006. 16: R62-64. https://doi.org/10.1016/j.cub.2006.01.004
-
Kim YS, Patel S, Lee SJ. Lack of direct role of parkin in the steady-state level and aggregation of
${\alpha}$ -synuclein and the clearance of pre-formed aggregates. Exp Neurol. 2006. 197: 538-541. https://doi.org/10.1016/j.expneurol.2005.10.024 -
Kimelman D, Xu W.
${\beta}$ -catenin destruction complex: insights and questions from a structural perspective. Oncogene. 2006. 25: 7482-7491. https://doi.org/10.1038/sj.onc.1210055 - Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998. 392: 605-608. https://doi.org/10.1038/33416
- Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene. 2000. 19: 1572-1578. https://doi.org/10.1038/sj.onc.1203437
-
Lee KH, Lee MH, Kang YW, Rhee K-J, Kim TU, Kim YS. Parkin induces apoptotic cell death in TNF-
${\alpha}$ -treated cervical cancer cells. BMB Rep. 2012. 45: 526-531. https://doi.org/10.5483/BMBRep.2012.45.9.104 - Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007. 2: 251-275. https://doi.org/10.1146/annurev.pathol.2.010506.134925
- Oates AJ, Schumaker LM, Jenkins SB, Pearce AA, DaCosta SA, Arun B, Ellis MJ. The mannose 6-phosphate /insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat. 1998. 47: 269-281. https://doi.org/10.1023/A:1005959218524
- Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004. 10: 2720-2724. https://doi.org/10.1158/1078-0432.CCR-03-0086
- Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci U S A. 2010. 107: 15145-15150. https://doi.org/10.1073/pnas.1009941107
-
Shang XZ, Zhu H, Lin K, Tu Z, Chen J, Nelson DR, Liu C. Stabilized
${\beta}$ -catenin promotes hepatocyte proliferation and inhibits TNF${\alpha}$ -induced apoptosis. Lab Invest. 2004. 84: 332-341. https://doi.org/10.1038/labinvest.3700043 - Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene. 1999. 18: 3913-3918. https://doi.org/10.1038/sj.onc.1202756
- Tay SP, Yeo CW, Chai C, Chua PJ, Tan HM, Ang AX, Yip DL, Sung JX, Tan PH, Bay BH, Wong SH, Tang C, Tan JM, Lim KL. Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem. 2010. 285: 29231-29238. https://doi.org/10.1074/jbc.M110.108241
- Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010. 42: 77-82. https://doi.org/10.1038/ng.491
- Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, Schule B, Klein C, Shridhar V, Roberts LR, Smith DI. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer. 2004. 40: 85-96. https://doi.org/10.1002/gcc.20020